Cargando…
A Scoping Review on Use of Drugs Targeting the JAK/STAT Pathway in Psoriasis
INTRODUCTION: The Janus kinase–signal transducer and activator of transcription (JAK/STAT) pathway are known to be involved in inflammatory immune-mediated skin diseases, including psoriasis. The development of drugs targeting the JAK/STAT signaling pathway presents new treatment opportunities for p...
Autores principales: | Gómez-García, Francisco, Gómez-Arias, Pedro Jesús, Montilla-López, Ana, Hernández-Parada, Jorge, Sanz-Cabanillas, Juan Luís, Ruano, Juan, Parra-Peralbo, Esmeralda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914468/ https://www.ncbi.nlm.nih.gov/pubmed/35280877 http://dx.doi.org/10.3389/fmed.2022.754116 |
Ejemplares similares
-
Efficacy and Safety of Janus Kinase Inhibitors in Type I Interferon-Mediated Monogenic Autoinflammatory Disorders: A Scoping Review
por: Gómez-Arias, Pedro Jesús, et al.
Publicado: (2021) -
Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
por: Montilla, Ana M., et al.
Publicado: (2019) -
Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review
por: Gómez-García, Francisco, et al.
Publicado: (2019) -
A Scoping Review Protocol to Explore the Use of Interleukin-1-Targeting Drugs for the Treatment of Dermatological Diseases: Indications, Mechanism of Action, Efficacy, and Safety
por: Gómez-García, Francisco, et al.
Publicado: (2018) -
Scoping Review on Use of Drugs Targeting Interleukin 1 Pathway in DIRA and DITRA
por: Gómez-García, Francisco, et al.
Publicado: (2018)